![]() |
|
|
Vol. 291, Issue 1, 374-382, October 1999
Department of Anatomy and Cell Biology, Columbia University, New
York, New York (J.Z., M.D.G., A.L.K.); and Center for Ulcer Research,
UCLA (J.H.W., H.C.W.), Los Angeles, California
The whole-cell patch-clamp technique was used to analyze the effects of
5-hydroxytryptamine (5-HT) and alosetron on cultured myenteric neurons
from newborn guinea pigs. All neurons responded to 5-HT
(EC50 ~ 38.7 µM) with a concentration-dependent
inward current (reversal potential = 7.1 ± 1.7 mV) with a
short latency and rapid decay. Because the 5-HT-induced inward current
was mimicked by 2-methyl-5-hydroxytryptamine (50 µM) and blocked by
ondansetron (5.0 µM) and MDL 72222 (0.05 µM), it was
5-HT3-mediated. Alosetron blocked
(IC50 ~ 0.05 µM; Hill coefficient ~ 1.24)
the 5-HT- and 2-methyl-5-hydroxytryptamine-induced inward currents.
This effect was independent of membrane potential and was not seen when
alosetron was delivered to the inside of cells. Alosetron-sensitive
sites are, thus, accessible only on the ectodomain of the plasmalemma. The effect of alosetron was reversible, but not surmountable. Although
nicotine (100 µM) mimicked the 5-HT-induced inward current, the
response was antagonized by hexamethonium (100 µM), but not by
alosetron, implying its potential to be a selective 5-HT3
antagonist. Hexamethonium did not affect responses to 5-HT. Most
neurons in the cultures were 5-HT-immunoreactive and immunostained with
an antibody raised against 5-HT3 receptors. The
5-HT-selective uptake inhibitor, fluoxetine (30 µM), gradually
reduced the amplitude of the current induced by 5-HT; the residual
response was abolished by alosetron (0.2 µM). The effect of
fluoxetine could have been caused by either the desensitization of
5-HT3 receptors or by a nonspecific 5-HT3
antagonistic effect of fluoxetine. It is concluded that alosetron is a
potent and noncompetitive 5-HT3 antagonist on myenteric neurons.
This article has been cited by other articles:
![]() |
M. Liu, M. S. Geddis, Y. Wen, W. Setlik, and M. D. Gershon Expression and function of 5-HT4 receptors in the mouse enteric nervous system Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1148 - G1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Lin, C. Neevel, and J. H. Chen Slowing intestinal transit by PYY depends on serotonergic and opioid pathways Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G558 - G563. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Raybould, J. Glatzle, C. Robin, J. H. Meyer, T. Phan, H. Wong, and C. Sternini Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G367 - G372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, H.-Z. Hu, N. Gao, C. Gao, G. Wang, X. Wang, O. C. Peck, G. Kim, X. Gao, Y. Xia, et al. Neuroimmune interactions in guinea pig stomach and small intestine Am J Physiol Gastrointest Liver Physiol, January 1, 2003; 284(1): G154 - G164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Liu, S. Rayport, Y. Jiang, D. L. Murphy, and M. D. Gershon Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1398 - G1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A Hicks, J. R Coldwell, M. Schindler, P. A Bland Ward, D. Jenkins, P. A Lynn, P. P A Humphrey, and L A. Blackshaw Excitation of rat colonic afferent fibres by 5-HT3 receptors J. Physiol., November 1, 2002; 544(3): 861 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. W. Fu, D. Wang, J. Pan, S. M. Farragher, V. Wong, and E. Cutz Neuroepithelial bodies in mammalian lung express functional serotonin type 3 receptor Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L931 - L940. [Abstract] [Full Text] [PDF] |
||||